Nikhil S. Gadewal
Navi Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
The deubiquitinase inhibitor WP1130 drives nuclear aggregation and reactivation of mutant p53 for selective cancer cell targeting.
Journal: The FEBS journal
Published: November 15, 2024
In silico screening of phytochemicals against chromatin modifier, SETD7 for remodeling of the immunosuppressive tumor microenvironment in renal cancer.
Journal: Molecular diversity
Published: June 04, 2024
Mechanistic influence of discreet conformation of human telomerase linker region.
Journal: Journal of biomolecular structure & dynamics
Published: February 06, 2024
High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer.
Journal: Neoplasia (New York, N.Y.)
Published: November 05, 2023
Integrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma.
Journal: Biochimica et biophysica acta. General subjects
Published: June 16, 2023
Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer.
Journal: International journal of biological macromolecules
Published: November 08, 2022
Loss of correlated proteasomal subunit expression selectively promotes the 20SHigh state which underlies luminal breast tumorigenicity.
Journal: Communications biology
Published: April 08, 2022
ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and β-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications.
Journal: Cancer gene therapy
Published: February 11, 2022
Molecular docking analysis of hyperphosphorylated tau protein with compounds derived from Bacopa monnieri and Withania somnifera.
Journal: Bioinformation
Published: August 16, 2021
Downregulation of ARID1B, a tumor suppressor in the WNT subgroup medulloblastoma, activates multiple oncogenic signaling pathways.
Journal: Human molecular genetics
Published: April 02, 2021
Last Updated: 09/26/2026